Phathom Pharmaceuticals, Inc. (PHAT) Financials
PHAT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 237.0 million | 254.8 million |
2023-06-30 | 265.0 million | 247.4 million |
2023-03-31 | 144.0 million | 234.2 million |
2022-12-31 | 164.8 million | 239.6 million |
PHAT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -32.9 million | 6.1 million |
2023-06-30 | -22.2 million | 7.3 million |
2023-03-31 | -39.9 million | 7.0 million |
2022-12-31 | -41.1 million | 6.7 million |
PHAT Net Income
No data available :(
PHAT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 213.7 million | - | 1.3 million |
2023-06-30 | 248.8 million | - | 1.5 million |
2023-03-31 | 129.6 million | 96.6 million | 1.7 million |
2022-12-31 | 155.4 million | - | 1.8 million |
PHAT Shares Outstanding
PHAT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 939000 | 12.3 million | 23.4 million | - |
2023-06-30 | 6000 | 12.8 million | 18.9 million | - |
2023-03-31 | 214000 | 11.5 million | 18.6 million | - |
2022-12-31 | 412000 | 15.9 million | 30.7 million | - |
PHAT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 121000 |
2023-06-30 | - | 123000 |
2023-03-31 | - | 146000 |
2022-12-31 | - | 168000 |
PHAT
Price: $10.04
52 week price:
Earnings Per Share: -3.93 USD
P/E Ratio: -1.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 521200
Market Capitalization: 612.3 million